Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 2,431 | 0 | 971 | 2,670 | 1,170 |
| Gross Profit | 2,431 | N/A | 971 | 2,670 | 1,170 |
| Operating Expenses | 30,213 | 24,904 | 18,646 | 16,227 | 14,463 |
| Operating Income | -27,782 | -24,904 | -17,675 | -13,557 | -13,293 |
| Interest Expense | 2,220 | 549 | 796 | 487 | 127 |
| Other Income | 10 | -430 | -2,423 | -195 | -7 |
| Pre-tax Income | -29,992 | -25,883 | -20,894 | -14,239 | -13,427 |
| Net Income Continuous | -29,992 | -25,883 | -20,894 | -14,239 | -13,427 |
| Net Income | $-29,992 | $-25,883 | $-20,894 | $-14,239 | $-13,427 |
| EPS Basic Total Ops | -1.18 | -1.27 | -3.54 | -13.06 | -16.16 |
| EPS Basic Continuous Ops | -1.18 | -1.27 | -3.54 | -13.06 | -16.16 |
| EPS Diluted Total Ops | -1.18 | -1.27 | -3.54 | -13.06 | -16.16 |
| EPS Diluted Continuous Ops | -1.18 | -1.27 | -3.54 | -13.06 | -16.16 |
| EBITDA(a) | $-26,919 | $-24,384 | $-16,710 | $-12,883 | $-12,598 |